Title
Category
Credits
Event date
Cost
Lymphoma Management in North Carolina: Updates for 2023
  • Research to Practice
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 ASRT
  • 1.00 CTR Category A
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Natalie Grover, MD, will review some of the recent advances in the treatment of lymphoma, including the incorporation of novel targeted agents in the frontline treatment of diffuse large B cell lymphoma and Hodgkin lymphoma, the use of CAR-T cell therapy in second-line treatment in diffuse large B cell lymphoma, and recently approved drugs by the FDA for lymphoma.
H. Pylori Testing and Treatment for Gastric Cancer Prevention
  • Research to Practice
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ASRT
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Katherine Garman, MD, and Meira Epplein, PhD, will provide information on gastric cancer and important risk factors such as H. pylori infection. We will describe some of the racial disparities associated with gastric cancer in the US, highlighting those that are relevant for North Carolina. We will also discuss H. pylori as a modifiable risk factor and we will review current guidelines on H. pylori testing, treatment, eradication testing, and the growing problem of antibiotic resistance.
Caring for Older Adults with Acute Leukemia in North Carolina
  • Research to Practice
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Daniel Richardson, MD, MA, MSc, will explore best practices to approach the care of older adults with leukemia. He will also discuss novel therapeutic options for patients with acute lymphoblastic and acute myeloid leukemia alongside practical considerations to approach shared decision-making.
The Umbrella and the Kitchen Table: Providing Safe, Supportive Care for Cancer Patients
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Introduction and discussion of supportive care programs in a "home away from home" for patients during their cancer journey.
Immune (check point) Related Adverse Events - SPOC
  • Research to Practice
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 AMA PRA Category 1 Credit™
  • 1.50 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Frances Collichio, MD, reviews the common and uncommon side effects of immune check point inhibitors. She also discusses the relatively new concept of delayed immune related events.
Primary Brain Tumors: Diagnosis and Management Strategies - SPOC
  • Research to Practice
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 AMA PRA Category 1 Credit™
  • 1.25 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Dominique Higgins, MD, PhD, provides an overview of diagnostic criteria for primary CNS brain tumors, and the current approved and investigational treatments that are available and on the horizon.
Oncologic Emergencies - SPOC
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 AMA PRA Category 1 Credit™
  • 1.50 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Jacob Stein, MD, MPH, reviews several of the most common medical emergencies that arise when caring for patients with cancer. We highlight key aspects of presentation, diagnosis and management, with pearls for clinicians along the way.
Solid Organ Transplantation and Skin Cancer
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Puneet Singh Jolly, MD, PhD discusses keratinocyte neoplasms are by far the most common malignancy in the world. While surgical treatments remain the most common and most effective therapy, there are numerous emerging non-surgical techniques. We discuss these and the rationale for using such treatments, particularly in specific challenging clinical scenarios.
Update on Prostate Cancer Screening
  • Research to Practice
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 AMA PRA Category 1 Credit™
  • 1.25 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Marc Bjurlin, DO, MSc, FACOS, gives a contemporary overview of prostate cancer screening with a focus on prostate cancer in men in North Carolina.
From Bench to Bedside: Molecular Oncology's Role in Personalized Cancer Diagnosis and Treatment
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
05/08/2024
$0.00
Lori Ramkissoon, PhD will review advancements in molecular oncology and demonstrate how this integration of this testing has advanced treatment strategies and improved patient outcomes for diverse cancer types.

Pages